XML 26 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 216,222 $ 209,170
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 159,448 154,223
Non-cash compensation expense 10,069 11,011
Income from unconsolidated joint ventures (1,791) (14,834)
Distributions of net cash flow from operations of unconsolidated joint ventures 10,718 1,350
Gains from investments in securities (259) (393)
Non-cash portion of interest expense (10,138) (10,884)
Gains on sales of real estate (67,623) (95,084)
Change in assets and liabilities:    
Cash held in escrows 1,940 1,044
Tenant and other receivables, net 25,018 (1,173)
Accrued rental income, net (12,981) (23,250)
Prepaid expenses and other assets 45,560 3,447
Accounts payable and accrued expenses (5,209) (5,535)
Accrued interest payable 31,192 23,098
Other liabilities (33,319) (23,136)
Tenant leasing costs (19,867) (27,608)
Total adjustments 132,758 (7,724)
Net cash provided by operating activities 348,980 201,446
Cash flows from investing activities:    
Construction in progress (122,940) (60,013)
Building and other capital improvements (25,329) (19,391)
Tenant improvements (55,739) (26,950)
Proceeds from sales of real estate 104,816 194,821
Proceeds from sales of real estate placed in escrow (104,696) (201,857)
Proceeds from sales of real estate released from escrow 104,696 99,916
Cash released from scrow for land sale contracts 488 0
Deposit on real estate 0 (5,000)
Capital contributions to unconsolidated joint ventures (10,215) (2,444)
Capital distributions from unconsolidated joint ventures 0 24,527
Investments in securities, net (438) (884)
Net cash provided by (used in) investing activities (109,357) 2,725
Cash flows from financing activities:    
Repayments of mortgage notes payable (6,265) (7,024)
Proceeds from unsecured senior notes 997,080 0
Proceeds from real estate financing transaction 0 6,000
Payments on real estate financing transactions (781) (636)
Deferred financing costs (8,047) (20)
Net proceeds from equity transactions (657) (145)
Dividends and distributions (328,567) (883,684)
Contributions from noncontrolling interests in property partnerships 2,489 629
Distributions to noncontrolling interests in property partnerships (12,915) (17,974)
Net cash provided by (used in) financing activities 642,337 (902,854)
Net increase (decrease) in cash and cash equivalents 881,960 (698,683)
Cash and cash equivalents, beginning of period 723,718 1,763,079
Cash and cash equivalents, end of period 1,605,678 1,064,396
Supplemental disclosures:    
Cash paid for interest 93,524 104,508
Interest capitalized 9,269 7,965
Non-cash investing and financing activities:    
Additions to real estate included in accounts payable and accrued expenses (24,857) 9,243
Dividends and distributions declared but not paid 113,079 112,796
Conversions of noncontrolling interests to stockholders’ equity 446 8,689
Issuance of restricted securities to employees 32,630 42,279
Boston Properties Limited Partnership    
Cash flows from operating activities:    
Net income 220,378 211,169
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 157,461 152,224
Non-cash compensation expense 10,069 11,011
Income from unconsolidated joint ventures (1,791) (14,834)
Distributions of net cash flow from operations of unconsolidated joint ventures 10,718 1,350
Gains from investments in securities (259) (393)
Non-cash portion of interest expense (10,138) (10,884)
Gains on sales of real estate (69,792) (95,084)
Change in assets and liabilities:    
Cash held in escrows 1,940 1,044
Tenant and other receivables, net 25,018 (1,173)
Accrued rental income, net (12,981) (23,250)
Prepaid expenses and other assets 45,560 3,447
Accounts payable and accrued expenses (5,209) (5,535)
Accrued interest payable 31,192 23,098
Other liabilities (33,319) (23,136)
Tenant leasing costs (19,867) (27,608)
Total adjustments 128,602 (9,723)
Net cash provided by operating activities 348,980 201,446
Cash flows from investing activities:    
Construction in progress (122,940) (60,013)
Building and other capital improvements (25,329) (19,391)
Tenant improvements (55,739) (26,950)
Proceeds from sales of real estate 104,816 194,821
Proceeds from sales of real estate placed in escrow (104,696) (201,857)
Proceeds from sales of real estate released from escrow 104,696 99,916
Cash released from scrow for land sale contracts 488 0
Deposit on real estate 0 (5,000)
Capital contributions to unconsolidated joint ventures (10,215) (2,444)
Capital distributions from unconsolidated joint ventures 0 24,527
Investments in securities, net (438) (884)
Net cash provided by (used in) investing activities (109,357) 2,725
Cash flows from financing activities:    
Repayments of mortgage notes payable (6,265) (7,024)
Proceeds from unsecured senior notes 997,080 0
Proceeds from real estate financing transaction 0 6,000
Payments on real estate financing transactions (781) (636)
Deferred financing costs (8,047) (20)
Net proceeds from equity transactions (657) (145)
Dividends and distributions (328,567) (883,684)
Contributions from noncontrolling interests in property partnerships 2,489 629
Distributions to noncontrolling interests in property partnerships (12,915) (17,974)
Net cash provided by (used in) financing activities 642,337 (902,854)
Net increase (decrease) in cash and cash equivalents 881,960 (698,683)
Cash and cash equivalents, beginning of period 723,718 1,763,079
Cash and cash equivalents, end of period 1,605,678 1,064,396
Supplemental disclosures:    
Cash paid for interest 93,524 104,508
Interest capitalized 9,269 7,965
Non-cash investing and financing activities:    
Additions to real estate included in accounts payable and accrued expenses (24,857) 9,243
Dividends and distributions declared but not paid 113,079 112,796
Conversions of noncontrolling interests to stockholders’ equity (446) (8,689)
Issuance of restricted securities to employees $ 32,630 $ 42,279